You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
立方製藥(003020.SZ):丙胺卡因原料藥上市登記申請獲受理
格隆匯 04-28 19:57

格隆匯4月28日丨立方製藥(003020.SZ)公佈,近日,公司收到國家藥品監督管理局下發的丙胺卡因原料藥上市登記申請《受理通知書》。

丙胺卡因屬於酰胺類局部麻醉藥,適用於硬膜外麻醉、傳導麻醉和浸潤麻醉等。原料藥、藥用輔料和藥包材登記信息平台中,丙胺卡因共有9條登記信息,其中僅一家公司的登記號狀態為A(已批准在上市制劑使用的原料/輔料/包材),其餘登記狀態均為I(尚未通過與製劑共同審評審批的原料/輔料/包材)。

丙胺卡因原料藥上市登記申請獲得受理,表示該品種進入註冊審評階段,對公司近期業績不會產生影響。如丙胺卡因順利通過註冊審評,將進一步豐富公司原料藥產品管線。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account